Skip to main content

Sector Gamma As

13F filer · CIK 0001475373
Reported Aug 12, 2026
Net seller this quarter
13F portfolio value$461MU.S. long equity reported on 13F
Positions406 new · 8 closed
Net flow last quarter-$3.59MBuys minus sells
Top 10 positions weight48.4%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 12, 202640 positions
BMYBristol Myers Squibb Co$41.8M9.08%0.04%-12.3%Q2 2014
MRKMerck & Co., Inc.$27.9M6.05%0.01%-16.6%Q1 2016
MDTMedtronic plc$27.6M5.98%0.03%+25.6%Q2 2020
PFEPfizer Inc$24.2M5.25%0.02%-8.0%Q4 2020
INCYIncyte Corp$19.4M4.20%0.09%-14.8%Q3 2018
ELVElevance Health, Inc.$17.2M3.73%0.02%+1.2%Q2 2016
BMRNBiomarin Pharmaceutical Inc$16.9M3.66%0.15%+22.9%Q4 2019
TMOThermo Fisher Scientific Inc.$16.8M3.65%0.01%Not reportedQ2 2013
CVSCVS HEALTH Corp$16.1M3.49%0.01%+14.8%Q4 2018
IQVIqvia Holdings Inc.$15.1M3.27%0.05%+93.8%Q1 2026
IONSIonis Pharmaceuticals Inc$15M3.26%0.11%+11.8%Q4 2017
BDXBecton Dickinson & Co$14.1M3.06%0.03%+12.8%Q4 2020
ABTAbbott Laboratories$13.4M2.90%0.01%+68.5%Q2 2016
GEHCGE HealthCare Technologies Inc.$13.3M2.89%0.05%+64.4%Q2 2023
ZBHZimmer Biomet Holdings, Inc.$12.3M2.66%0.07%-8.7%Q1 2022
BIIBBiogen Inc.$11.7M2.54%0.04%-39.9%Q4 2013
QGENQiagen N.V.$11.2M2.44%0.13%+77.2%Q4 2018
CNCCentene Corp$10.4M2.26%0.03%Not reportedQ4 2020
REGNRegeneron Pharmaceuticals, Inc.$9.84M2.13%0.02%Not reportedQ2 2018
BIOBio-Rad Laboratories, Inc.$9.79M2.12%0.12%+40.4%Q2 2013
CAHCardinal Health Inc$9.67M2.10%0.02%-25.9%Q2 2013
AMGNAmgen Inc$9.52M2.06%0.00%-44.3%Q2 2024
BRKRBruker Corp$9.17M1.99%0.10%-40.0%Q2 2019
AVTRAvantor, Inc.$8.97M1.95%0.13%+30.3%Q2 2025
PTCTPTC Therapeutics, Inc.$8.16M1.77%0.12%+33.3%Q1 2019
LHLabcorp Holdings Inc.$7.29M1.58%0.03%+36.8%Q2 2025
DXCMDexcom Inc$6.88M1.49%0.03%+82.0%Q2 2025
ASNDAscendis Pharma A/S$5.68M1.23%0.03%Not reportedQ1 2025
EWEdwards Lifesciences Corp$5.46M1.19%0.01%Not reportedQ3 2013
SNDXSyndax Pharmaceuticals Inc$5.28M1.15%0.27%-15.5%Q3 2025
BSXBoston Scientific Corp$5.17M1.12%0.01%Not reportedQ2 2013
KURAKura Oncology, Inc.$4.75M1.03%0.49%+5.2%Q3 2025
TVTXTravere Therapeutics, Inc.$4.54M0.99%0.08%NewQ2 2026
CRNXCrinetics Pharmaceuticals, Inc.$4.29M0.93%0.11%+21.7%Q4 2025
TNDMTandem Diabetes Care Inc$4.03M0.87%0.38%Not reportedQ1 2025
IOVAIovance Biotherapeutics, Inc.$4.03M0.87%0.21%+7.6%Q1 2026
CYTKCytokinetics Inc$3.83M0.83%0.04%NewQ2 2026
OGNOrganon & Co.$3.67M0.80%0.10%-28.0%Q2 2021
ARDXArdelyx, Inc.$3.5M0.76%0.28%+33.1%Q1 2026
NTLAIntellia Therapeutics, Inc.$3.13M0.68%0.13%NewQ2 2026
Q1 2026Reported May 7, 202642 positions
BMYBristol Myers Squibb Co$50.2M11.86%0.04%+11.0%Q2 2014
MRKMerck & Co., Inc.$31.3M7.39%0.01%-28.4%Q1 2016
PFEPfizer Inc$30.6M7.24%0.02%+27.0%Q4 2020
MDTMedtronic plc$24.3M5.74%0.02%+4.1%Q2 2020
INCYIncyte Corp$18.9M4.46%0.10%-8.4%Q3 2018
AMGNAmgen Inc$16.6M3.92%0.01%-22.6%Q2 2024
BIIBBiogen Inc.$16.5M3.90%0.06%+5.4%Q4 2013
ZBHZimmer Biomet Holdings, Inc.$14.1M3.33%0.08%+17.6%Q1 2022
BMRNBiomarin Pharmaceutical Inc$13.6M3.20%0.12%+20.9%Q4 2019
BDXBecton Dickinson & Co$13M3.07%0.03%-37.6%Q4 2020
ELVElevance Health, Inc.$12.9M3.04%0.02%+35.1%Q2 2016
IONSIonis Pharmaceuticals Inc$12.7M3.00%0.10%-8.4%Q4 2017
CAHCardinal Health Inc$11.6M2.74%0.02%-11.4%Q2 2013
UNHUnitedhealth Group Inc$9.86M2.33%0.00%Not reportedQ2 2013
CVSCVS HEALTH Corp$9.72M2.30%0.01%-23.8%Q4 2018
BRKRBruker Corp$9.17M2.17%0.17%-0.3%Q2 2019
GEHCGE HealthCare Technologies Inc.$9M2.12%0.03%+10.5%Q2 2023
ABTAbbott Laboratories$8.99M2.12%0.01%Not reportedQ2 2016
GILDGilead Sciences, Inc.$7.42M1.75%0.00%-69.8%Q3 2016
LNTHLantheus Holdings, Inc.$7.08M1.67%0.14%-0.5%Q2 2023
IQVIqvia Holdings Inc.$6.86M1.62%0.02%NewQ1 2026
SNDXSyndax Pharmaceuticals Inc$6.68M1.58%0.32%+13.5%Q3 2025
BIOBio-Rad Laboratories, Inc.$6.62M1.56%0.09%Not reportedQ2 2013
QGENQiagen N.V.$6.5M1.54%0.07%Not reportedQ4 2018
AVTRAvantor, Inc.$5.45M1.29%0.10%Not reportedQ2 2025
CNCCentene Corp$5.32M1.26%0.03%-37.1%Q4 2020
TNDMTandem Diabetes Care Inc$5.12M1.21%0.39%Not reportedQ1 2025
PTCTPTC Therapeutics, Inc.$5.11M1.21%0.09%+21.1%Q1 2019
LHLabcorp Holdings Inc.$5.07M1.20%0.02%-29.6%Q2 2025
ASNDAscendis Pharma A/S$4.87M1.15%0.03%+30.7%Q1 2025
EWEdwards Lifesciences Corp$4.84M1.14%0.01%-37.3%Q3 2013
DXCMDexcom Inc$3.52M0.83%0.01%-26.3%Q2 2025
CRNXCrinetics Pharmaceuticals, Inc.$3.42M0.81%0.09%-18.1%Q4 2025
KURAKura Oncology, Inc.$3.35M0.79%0.46%-9.7%Q3 2025
HUMHumana Inc$3.33M0.79%0.02%Not reportedQ2 2019
BBIOBridgeBio Pharma, Inc.$3.29M0.78%0.02%NewQ1 2026
IOVAIovance Biotherapeutics, Inc.$3.16M0.75%0.21%NewQ1 2026
DNLIDenali Therapeutics Inc.$3.12M0.74%0.10%NewQ1 2026
ARDXArdelyx, Inc.$3.09M0.73%0.21%NewQ1 2026
COGTCogent Biosciences, Inc.$3.08M0.73%0.05%NewQ1 2026
OGNOrganon & Co.$2.25M0.53%0.14%+25.3%Q2 2021
ARWRArrowhead Pharmaceuticals, Inc.$1.88M0.44%0.02%NewQ1 2026
Q4 2025Reported Feb 12, 202636 positions
BMYBristol Myers Squibb Co$40.2M9.17%0.04%+28.3%Q2 2014
MRKMerck & Co., Inc.$38.3M8.73%0.01%+12.8%Q1 2016
MDTMedtronic plc$25.9M5.90%0.02%-11.1%Q2 2020
BDXBecton Dickinson & Co$25.7M5.86%0.05%+21.6%Q4 2020
GILDGilead Sciences, Inc.$21.7M4.94%0.01%+19.8%Q3 2016
INCYIncyte Corp$21.6M4.93%0.11%+6.7%Q3 2018
PFEPfizer Inc$21.4M4.88%0.02%-31.4%Q4 2020
AMGNAmgen Inc$20M4.55%0.01%-0.8%Q2 2024
BIIBBiogen Inc.$15M3.43%0.06%+13.3%Q4 2013
IONSIonis Pharmaceuticals Inc$14.6M3.34%0.11%-31.7%Q4 2017
CVSCVS HEALTH Corp$14.1M3.21%0.01%+13.7%Q4 2018
CAHCardinal Health Inc$12.7M2.90%0.03%+4.1%Q2 2013
TMOThermo Fisher Scientific Inc.$12.6M2.86%0.01%+17.6%Q2 2013
BRKRBruker Corp$12M2.73%0.17%+1.5%Q2 2019
ZBHZimmer Biomet Holdings, Inc.$11.9M2.72%0.07%+16.7%Q1 2022
BMRNBiomarin Pharmaceutical Inc$11.8M2.69%0.10%+12.9%Q4 2019
ELVElevance Health, Inc.$11.4M2.60%0.01%+238.9%Q2 2016
CNCCentene Corp$10.6M2.42%0.05%+21.1%Q4 2020
GEHCGE HealthCare Technologies Inc.$9.38M2.14%0.03%+2.7%Q2 2023
EWEdwards Lifesciences Corp$8.22M1.87%0.02%+32.1%Q3 2013
AVTRAvantor, Inc.$7.97M1.82%0.10%+45.8%Q2 2025
BIOBio-Rad Laboratories, Inc.$7.2M1.64%0.09%+4.0%Q2 2013
LHLabcorp Holdings Inc.$6.78M1.55%0.03%+4.0%Q2 2025
LNTHLantheus Holdings, Inc.$6.24M1.42%0.15%+45.7%Q2 2023
TNDMTandem Diabetes Care Inc$5.87M1.34%0.39%-0.9%Q1 2025
REGNRegeneron Pharmaceuticals, Inc.$5.53M1.26%0.01%Not reportedQ2 2018
CRNXCrinetics Pharmaceuticals, Inc.$5.35M1.22%0.12%NewQ4 2025
SNDXSyndax Pharmaceuticals Inc$5.3M1.21%0.29%+19.6%Q3 2025
DXCMDexcom Inc$5.05M1.15%0.02%-0.9%Q2 2025
HCAHCA Healthcare, Inc.$5.03M1.15%0.00%-0.9%Q2 2020
KURAKura Oncology, Inc.$4.74M1.08%0.52%+4.0%Q3 2025
PTCTPTC Therapeutics, Inc.$4.7M1.07%0.08%-47.6%Q1 2019
ASNDAscendis Pharma A/S$3.48M0.79%0.03%-33.0%Q1 2025
CGONCG Oncology, Inc.$2.16M0.49%0.06%NewQ4 2025
OGNOrganon & Co.$2.15M0.49%0.12%-44.8%Q2 2021
CERTCertara, Inc.$2.03M0.46%0.14%Not reportedQ3 2025
Q3 2025Reported Oct 31, 202541 positions
PFEPfizer Inc$31.9M7.91%0.02%+36.1%Q4 2020
MDTMedtronic plc$28.9M7.17%0.02%+35.5%Q2 2020
MRKMerck & Co., Inc.$27.1M6.71%0.01%+59.7%Q1 2016
BMYBristol Myers Squibb Co$26.2M6.50%0.03%+43.2%Q2 2014
BDXBecton Dickinson & Co$20.4M5.05%0.04%+11.1%Q4 2020
IONSIonis Pharmaceuticals Inc$17.7M4.40%0.17%-5.2%Q4 2017
INCYIncyte Corp$17.4M4.31%0.10%+0.6%Q3 2018
AMGNAmgen Inc$17.3M4.30%0.01%+39.7%Q2 2024
GILDGilead Sciences, Inc.$16.3M4.05%0.01%+15.9%Q3 2016
CVSCVS HEALTH Corp$11.8M2.92%0.01%-4.2%Q4 2018
ZBHZimmer Biomet Holdings, Inc.$11.2M2.77%0.06%+28.0%Q1 2022
BIIBBiogen Inc.$10.6M2.62%0.05%+49.1%Q4 2013
BMRNBiomarin Pharmaceutical Inc$9.52M2.36%0.09%+43.7%Q4 2019
CAHCardinal Health Inc$9.34M2.32%0.02%-9.8%Q2 2013
TMOThermo Fisher Scientific Inc.$8.95M2.22%0.00%-27.7%Q2 2013
BAXBaxter International Inc$8.69M2.15%0.07%+42.4%Q2 2013
GEHCGE HealthCare Technologies Inc.$8.37M2.07%0.02%+50.5%Q2 2023
BRKRBruker Corp$8.15M2.02%0.17%+28.0%Q2 2019
CNCCentene Corp$7.61M1.89%0.04%+40.3%Q4 2020
LHLabcorp Holdings Inc.$7.45M1.85%0.03%+33.3%Q2 2025
PTCTPTC Therapeutics, Inc.$7.25M1.80%0.15%+28.0%Q1 2019
VTRSViatris Inc$6.62M1.64%0.06%Not reportedQ1 2024
BIOBio-Rad Laboratories, Inc.$6.4M1.59%0.08%+28.0%Q2 2013
HUMHumana Inc$6.23M1.54%0.02%+1.9%Q2 2019
ELANElanco Animal Health Inc$6.19M1.53%0.06%+5.2%Q1 2019
AVTRAvantor, Inc.$5.95M1.48%0.07%+28.0%Q2 2025
OGNOrganon & Co.$5.81M1.44%0.21%Not reportedQ2 2021
EWEdwards Lifesciences Corp$5.68M1.41%0.01%+73.8%Q3 2013
DXCMDexcom Inc$5.17M1.28%0.02%+53.6%Q2 2025
ASNDAscendis Pharma A/S$4.84M1.20%0.04%+43.1%Q1 2025
HCAHCA Healthcare, Inc.$4.64M1.15%0.00%+36.0%Q2 2020
ICLRIcon PLC$4.37M1.08%0.03%NewQ3 2025
SOLVSolventum Corp$4.33M1.07%0.03%+55.9%Q1 2025
KURAKura Oncology, Inc.$3.88M0.96%0.50%NewQ3 2025
LNTHLantheus Holdings, Inc.$3.3M0.82%0.09%+28.0%Q2 2023
TNDMTandem Diabetes Care Inc$3.27M0.81%0.40%+28.0%Q1 2025
SNDXSyndax Pharmaceuticals Inc$3.24M0.80%0.24%NewQ3 2025
ELVElevance Health, Inc.$3.1M0.77%0.00%-48.9%Q2 2016
CERTCertara, Inc.$2.82M0.70%0.14%NewQ3 2025
BNTXBioNTech SE$2.73M0.68%0.01%-26.0%Q1 2021
ACLXArcellx, Inc.$2.63M0.65%0.06%+28.0%Q1 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.